Improving the prediction of drug disposition in the brain

Bibliography

• Abbott NJ. Prediction of blood-brain barrier permeation in drug discovery from in vivo, in vitro and in silico models. Drug Discov Today Technol 2004;1(4):407-16
   PubMedGoogle Scholar
• Mensch J, Oyarzabal J, Mackie C, Augustijns P. In vivo, in vitro and in silico methods for small molecule transfer across the BBB. J Pharm Sci 2009;98(12):4429-68
   PubMed Web of Science ®Google Scholar
• Abbott NJ, Patabendige AAK, Dolman DEM, Structure and function of the blood-brain barrier. Neurobiol Dis 2010;37(1):13-25
   PubMed Web of Science ®Google Scholar
• Wager TT, Liras JL, Mente S, Trapa P. Strategies to minimize CNS toxicity: in vitro high-throughput assays and computational modeling. Expert Opin Drug Metab Toxicol 2012;8(5):531-42
   PubMed Web of Science ®Google Scholar
• Tomé AM, Filipe A. Quinolones: review of psychiatric and neurological adverse reactions. Drug Saf 2011;34(6):465-88
   PubMed Web of Science ®Google Scholar
• Grill MF, Maganti RK. Neurotoxic effects associated with antibiotic use: management considerations. Br J Clin Pharmacol 2011;72(3):381-93
   PubMed Web of Science ®Google Scholar
• Aygün D, Kaplan S, Odaci E, Toxicity of non-steroidal anti-inflammatory drugs: a review of melatonin and diclofenac sodium association. Histol Histopathol 2012;27(4):417-36
   PubMed Web of Science ®Google Scholar
• Easter A, Bell ME, Damewood JR Jr, Approaches to seizure risk assessment in preclinical drug discovery. Drug Discov Today 2009;14(17-18):876-84
   PubMed Web of Science ®Google Scholar
• Rinne ML, Lee EQ, Wen PY. Central nervous system complications of cancer therapy. J Support Oncol 2012;10(4):133-41
   PubMedGoogle Scholar
• Goodwin JT, Clark DE. In Silico Predictions of Blood-Brain Barrier Penetration: considerations to “Keep in Mind”. J Pharmacol Exp Ther 2005;315:477-83
   PubMed Web of Science ®Google Scholar
• Hammarlund-Udenaes M, Fridén M, Syvänen S, Gupta A. On the rate and extent of drug delivery to the brain. Pharm Res 2008;25(8):1737-50
   PubMed Web of Science ®Google Scholar
• Jeffrey P, Summerfield SG. Challenges for blood-brain barrier (BBB) screening. Xenobiotica 2007;37(10-11):1135-51
   PubMed Web of Science ®Google Scholar
• Schmidt S, Gonzalez D, Derendorf H. Significance of protein binding in pharmacokinetics and pharmacodynamics. J Pharm Sci 2010;99(3):1107-22
   PubMed Web of Science ®Google Scholar
• Yamazaki K, Kanaoka M. Computational prediction of the plasma protein-binding percent of diverse pharmaceutical compounds. J Pharm Sci 2004;93(6):1480-94
   PubMed Web of Science ®Google Scholar
• Bickel U. How to measure drug transport across the blood-brain barrier. NeuroRx 2005;2:15-26
   PubMedGoogle Scholar
• Di L, Kerns EH, Bezar IF, Comparison of blood-brain barrier permeability assays: in situ brain perfusion, MDR1-MDCKII and PAMPA-BBB. J Pharm Sci 2009;98(6):1980-91
   PubMed Web of Science ®Google Scholar
• Rodgers T, Leahy D, Rowland M. Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. J Pharm Sci 2005;94(6):1259-76
   PubMed Web of Science ®Google Scholar
• Rodgers T, Rowland M. Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. J Pharm Sci 2006;95(6):1238-57
   PubMed Web of Science ®Google Scholar
• Lanevskij K, Japertas P, Didziapetris R, Petrauskas A. Prediction of blood-brain barrier penetration by drugs. In: Jain KK, editor. Drug delivery to the central nervous system. Springer, New York; 2010. p. 63-83
   Google Scholar
• Cole S, Bagal S, El-Kattan A, Full efficacy with no CNS side-effects: unachievable panacea or reality? DMPK considerations in design of drugs with limited brain penetration. Xenobiotica 2012;42(1):11-27
   PubMed Web of Science ®Google Scholar
• Ohtsuki S, Terasaki T. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development. Pharm Res 2007;24(9):1745-58
   PubMed Web of Science ®Google Scholar
• Krajcsi P, Jani M, Tóth B, Efflux transporters in the blood-brain interfaces–in vitro and in vivo methods and correlations. Expert Opin Drug Metab Toxicol 2012;8(4):419-31
   PubMed Web of Science ®Google Scholar
• Rapoport SI, Ohno K, Pettigrew KD. Drug entry into the brain. Brain Res 1979;172(2):354-9
   PubMed Web of Science ®Google Scholar
• Levin VA. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem 1980;23(6):682-4
   PubMed Web of Science ®Google Scholar
• Gratton JA, Abraham MH, Bradbury MW, Chadha HS. Molecular factors influencing drug transfer across the blood-brain barrier. J Pharm Pharmacol 1997;49(12):1211-16
   PubMed Web of Science ®Google Scholar
• Abraham MH. Scales of solute hydrogen-bonding: their construction and application to physicochemical and biochemical processes. Chem Soc Rev 1993;22(2):73
   Web of Science ®Google Scholar
• Abraham MH, Chadha HS, Mitchell RC. Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain. J Pharm Sci 1994;83(9):1257-68
   PubMed Web of Science ®Google Scholar
• Abraham MH. The factors that influence permeation across the blood-brain barrier. Eur J Med Chem 2004;39:235-40
   PubMed Web of Science ®Google Scholar
• Avdeef A. Absorption and drug development. 1st edition. Wiley-Interscience, New York; 2003
   Google Scholar
• Liu X, Tu M, Kelly RS, Development of a computational approach to predict blood-brain barrier permeability. Drug Metab Dispos 2004;32(1):132-9
   PubMed Web of Science ®Google Scholar
• Smith QR, Allen DD. In situ brain perfusion technique. Methods Mol Med 2003;89:209-18
   PubMedGoogle Scholar
• Takasato Y, Rapoport SI, Smith QR. An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am J Physiol 1984;247(3 Pt 2):H484-93
   PubMed Web of Science ®Google Scholar
• Dagenais C, Rousselle C, Pollack GM, Scherrmann JM. Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice. J Cereb Blood Flow Metab 2000;20(2):381-6
   PubMed Web of Science ®Google Scholar
• Lanevskij K, Japertas P, Didziapetris R, Petrauskas A. Ionization-specific prediction of blood-brain permeability. J Pharm Sci 2009;98(1):122-34
   PubMed Web of Science ®Google Scholar
• Kubinyi H. Quantitative structure–activity relationships. 7. The bilinear model, a new model for nonlinear dependence of biological activity on hydrophobic character. J Med Chem 1977;20:625-9
   PubMed Web of Science ®Google Scholar
• Reynolds DP, Lanevskij K, Japertas P, Ionization-specific analysis of human intestinal absorption. J Pharm Sci 2009;98(11):4039-54
   PubMed Web of Science ®Google Scholar
• Dagenais C, Avdeef A, Tsinman O, P-glycoprotein deficient mouse in situ blood-brain barrier permeability and its prediction using an in combo PAMPA model. Eur J Pharm Sci 2009;38(2):121-37
   PubMed Web of Science ®Google Scholar
• Tsinman O, Tsinman K, Sun N, Avdeef A. Physicochemical selectivity of the BBB microenvironment governing passive diffusion–matching with a porcine brain lipid extract artificial membrane permeability model. Pharm Res 2011;28(2):337-63
   PubMed Web of Science ®Google Scholar
• Abraham MH. The permeation of neutral molecules, ions, and ionic species through membranes: brain permeation as an example. J Pharm Sci 2011;100(5):1690-701
   PubMed Web of Science ®Google Scholar
• Abraham MH, Acree WE Jr. Equations for the transfer of neutral molecules and ionic species from water to organic phases. J Org Chem 2010;75(4):1006-15
   PubMed Web of Science ®Google Scholar
• Summerfield SG, Read K, Begley DJ, Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction. J Pharmacol Exp Ther 2007;322(1):205-13
   PubMed Web of Science ®Google Scholar
• Young RC, Mitchell RC, Brown TH, Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. J Med Chem 1988;31(3):656-71
   PubMed Web of Science ®Google Scholar
• Norinder U, Haeberlein M. Computational approaches to the prediction of the blood-brain distribution. Adv Drug Deliv Rev 2002;54(3):291-313
   PubMed Web of Science ®Google Scholar
• Lobell M, Molnár L, Keserü GM. Recent advances in the prediction of blood-brain partitioning from molecular structure. J Pharm Sci 2003;92(2):360-70
   PubMed Web of Science ®Google Scholar
• Clark DE. In silico prediction of blood-brain barrier permeation. Drug Discov Today 2003;8(20):927-33
   PubMed Web of Science ®Google Scholar
• Luco JM, Marchevsky E. QSAR Studies on blood-brain barrier permeation. Curr Comp-Aided Drug Des 2006;2:31-5
   Web of Science ®Google Scholar
• Mehdipour AR, Hamidi M. Brain drug targeting: a computational approach for overcoming blood-brain barrier. Drug Discov Today 2009;14(21-22):1030-6
   PubMed Web of Science ®Google Scholar
• Abraham MH, Ibrahim A, Zhao Y, Acree WE. A data base for partition of volatile organic compounds and drugs from blood/plasma/serum to brain, and an LFER analysis of the data. J Pharm Sci 2006;95(10):2091-100
   PubMed Web of Science ®Google Scholar
• Abraham MH, Acree WE, Leo AJ, Water-solvent partition coefficients and Delta Log P values as predictors for blood-brain distribution; application of the Akaike information criterion. J Pharm Sci 2010;99(5):2492-501
   PubMed Web of Science ®Google Scholar
• Fu X-C, Wang G-P, Shan H-L, Predicting blood-brain barrier penetration from molecular weight and number of polar atoms. Eur J Pharm Biopharm 2008;70(2):462-6
   PubMed Web of Science ®Google Scholar
• Shayanfar A, Soltani S, Jouyban A. Prediction of blood-brain distribution: effect of ionization. Biol Pharm Bull 2011;34(2):266-71
   PubMed Web of Science ®Google Scholar
• Garg P, Verma J. In silico prediction of blood brain barrier permeability: an Artificial Neural Network model. J Chem Inf Model 2006;46(1):289-97
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhu H, Oprea TI, QSAR modeling of the blood-brain barrier permeability for diverse organic compounds. Pharm Res 2008;25(8):1902-14
   PubMed Web of Science ®Google Scholar
• Kortagere S, Chekmarev D, Welsh WJ, Ekins S. New predictive models for blood-brain barrier permeability of drug-like molecules. Pharm Res 2008;25(8):1836-45
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhu Q-J, Pan J, A prediction model for blood-brain barrier permeation and analysis on its parameter biologically. Comput Methods Programs Biomed 2009;95(3):280-7
   PubMed Web of Science ®Google Scholar
• Fan Y, Unwalla R, Denny RA, Insights for predicting blood-brain barrier penetration of CNS targeted molecules using QSPR approaches. J Chem Inf Model 2010;50(6):1123-33
   PubMed Web of Science ®Google Scholar
• Muehlbacher M, Spitzer GM, Liedl KR, Kornhuber J. Qualitative prediction of blood-brain barrier permeability on a large and refined dataset. J Comput Aided Mol Des 2011;25(12):1095-106
   PubMed Web of Science ®Google Scholar
• Tropsha A. Best practices for QSAR model development, validation, and exploitation. Mol Inform 2010;29(6-7):476-88
   PubMed Web of Science ®Google Scholar
• Lanevskij K, Dapkunas J, Juska L, QSAR analysis of blood-brain distribution: the influence of plasma and brain tissue binding. J Pharm Sci 2011;100(6):2147-60
   PubMed Web of Science ®Google Scholar
• Tsuji A. Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems. NeuroRx 2005;2(1):54-62
   PubMedGoogle Scholar
• Kalvass JC, Maurer TS, Pollack GM. Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: comparison of unbound concentration ratios to in vivo p-glycoprotein efflux ratios. Drug Metab Dispos 2007;35(4):660-6
   PubMed Web of Science ®Google Scholar
• Fagerholm U. The highly permeable blood-brain barrier: an evaluation of current opinions about brain uptake capacity. Drug Discov Today 2007;12(23-24):1076-82
   PubMed Web of Science ®Google Scholar
• Jeffrey P, Summerfield S. Assessment of the blood-brain barrier in CNS drug discovery. Neurobiol Dis 2010;37(1):33-7
   PubMed Web of Science ®Google Scholar
• Reichel A. Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept. Chem Biodivers 2009;6(11):2030-49
   PubMed Web of Science ®Google Scholar
• ACD/Percepta. ACD/Labs, Inc. 110 Yonge Street, 14th floor, Toronto, Ontario, Canada M5C 1T4. Available from: http://acdlabs.com/products/percepta/
   Google Scholar
• Wan H, Rehngren M, Giordanetto F, High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery. J Med Chem 2007;50(19):4606-15
   PubMed Web of Science ®Google Scholar
• Wan H, Ahman M, Holmén AG. Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs. J Med Chem 2009;52(6):1693-700
   PubMed Web of Science ®Google Scholar
• Zamek-Gliszczynski MJ, Sprague KE, Espada A, How well do lipophilicity parameters, MEEKC microemulsion capacity factor, and plasma protein binding predict CNS tissue binding? J Pharm Sci 2012;101(5):1932-40
   PubMed Web of Science ®Google Scholar
• Fridén M, Winiwarter S, Jerndal G, Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids. J Med Chem 2009;52(20):6233-43
   PubMed Web of Science ®Google Scholar
• Chen H, Winiwarter S, Fridén M, In silico prediction of unbound brain-to-plasma concentration ratio using machine learning algorithms. J Mol Graph Model 2011;29(8):985-95
   PubMed Web of Science ®Google Scholar
• Adenot M, Lahana R. Blood-brain barrier permeation models: discriminating between potential CNS and non-CNS drugs including P-glycoprotein substrates. J Chem Inf Comput Sci 2004;44(1):239-48
   PubMedGoogle Scholar
• Zhao YH, Abraham MH, Ibrahim A, Predicting penetration across the blood-brain barrier from simple descriptors and fragmentation schemes. J Chem Inf Model 2007;47(1):170-5
   PubMed Web of Science ®Google Scholar
• Vilar S, Chakrabarti M, Costanzi S. Prediction of passive blood-brain partitioning: straightforward and effective classification models based on in silico derived physicochemical descriptors. J Mol Graph Model 2010;28(8):899-903
   PubMed Web of Science ®Google Scholar
• Lanevskij K, Japertas P, Didziapetris R, Petrauskas A. Ionization-specific QSAR models of blood-brain penetration of drugs. Chem Biodivers 2009;6(11):2050-4
   PubMed Web of Science ®Google Scholar
• Lanevskij K, Japertas P, Didziapetris R. Classification of drugs by CNS access: An insight from quantitative blood-brain transport characteristics. 243rd ACS National Meeting; 25 – 29 March 2012; San Diego, California. Available from: http://acdlabs.com/download/publ/2012/acss12_cns.pdf
   Google Scholar
• Liu X, Smith BJ, Chen C, Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding. J Pharmacol Exp Ther 2005;313(3):1254-62
   PubMed Web of Science ®Google Scholar
• Liu X, Chen C, Smith BJ. Progress in brain penetration evaluation in drug discovery and development. J Pharmacol Exp Ther 2008;325(2):349-56
   PubMed Web of Science ®Google Scholar
• Suenderhauf C, Hammann F, Huwyler J. Computational prediction of blood-brain barrier permeability using decision tree induction. Molecules 2012;17(9):10429-45
   PubMed Web of Science ®Google Scholar
• Martins IF, Teixeira AL, Pinheiro L, Falcao AO. A Bayesian approach to in silico blood-brain barrier penetration modeling. J Chem Inf Model 2012;52(6):1686-97
   PubMed Web of Science ®Google Scholar
• Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2005;2:3-14
   PubMedGoogle Scholar
• van de Waterbeemd H. Which in vitro screens guide the prediction of oral absorption and volume of distribution? Basic Clin Pharmacol Toxicol 2005;96(3):162-6
   PubMed Web of Science ®Google Scholar
• Veber DF, Johnson SR, Cheng H-Y, Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 2002;45(12):2615-23
   PubMed Web of Science ®Google Scholar
• Didziapetris R, Japertas P, Avdeef A, Petrauskas A. Classification analysis of P-glycoprotein substrate specificity. J Drug Target 2003;11(7):391-406
   PubMed Web of Science ®Google Scholar
• Ertl P, Rohde B, Selzer P. Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contribution and Its Application to the Prediction of Drug Transport Properties. J Med Chem 2000;43:3714-17
   PubMed Web of Science ®Google Scholar
• Gozalbes R, Barbosa F, Nicolaï E, Development and validation of a pharmacophore-based QSAR model for the prediction of CNS activity. ChemMedChem 2009;4(2):204-9
   PubMed Web of Science ®Google Scholar